Literature DB >> 12836475

Search for resolution of chiral fluorohalogenomethanes and parity-violation effects at the molecular level.

Jeanne Crassous1, Franck Monier, Jean-Pierre Dutasta, Michaël Ziskind, Christophe Daussy, Christophe Grain, Christian Chardonnet.   

Abstract

The first observation of a parity-violation effect in molecules induced by weak interactions is still a dream that requires the synthesis and, eventually, the resolution of the enantiomers of well-chosen simple chiral molecules together with an appropriate experimental set-up for high-resolution spectroscopy. Performing IR spectroscopy on highly enantiomerically enriched samples of bromochlorofluoromethane succeeded in giving an upper limit of 10(-13) for the relative vibrational energy difference between the two enantiomers. These results led us to conceive a new experimental set-up based on a supersonic molecular beam and to work on other chiral molecules, such as chlorofluoroiodomethane. A synthesis of (+/-)-CHCIFI from racemic chlorofluoroiodoacetic acid should, in the near future permit the preparation of optically active samples of this haloform. The development of molecular beam spectroscopy using a two-photon Ramsey-fringes experiment should allow us to reach the precision needed to observe parity violation. These experimental challenges, which stimulate a close collaboration between chemists and physicists, are presented. The success of these projects would open the route to new information on the molecular Hamiltonian, a better knowledge of the electroweak interaction, and a better control of the various chirality-related properties of simple molecules.

Entities:  

Year:  2003        PMID: 12836475     DOI: 10.1002/cphc.200200536

Source DB:  PubMed          Journal:  Chemphyschem        ISSN: 1439-4235            Impact factor:   3.102


  1 in total

1.  Parity violation energy of biomolecules--I: polypeptides.

Authors:  Francesco Faglioni; Alessio Passalacqua; Paolo Lazzeretti
Journal:  Orig Life Evol Biosph       Date:  2005-10       Impact factor: 1.950

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.